Male Hypogonadism Market Growth, Trends, and Forecast by 2031
Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031Coverage: Male Hypogonadism Market covers analysis by Therapy (Testosterone Replacement Therapy, Gonadotropin and Gonadotropin-Releasing Hormones Therapy); Drug Delivery (Topical Gels, Injectable, Transdermal Patches, Others); Type (Klinefelter's Syndrome, Kallmann Syndrome, Pituitary Disorders, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)
- Report Date : Oct 2025
- Report Code : TIPRE00008244
- Category : Life Sciences
- Status : Upcoming
- Available Report Formats :
- No. of Pages : 150
AI overview of Male Hypogonadism Market
The Male Hypogonadism Market is poised for significant growth, projected to reach a market size of US$ XX million by 2031, with a compound annual growth rate (CAGR) of 5.1% from 2025 to 2031. This growth is driven by the rising prevalence of lifestyle diseases and increasing awareness about male hypogonadism. The market is segmented into various therapies, including testosterone replacement therapy and gonadotropin treatments, as well as diverse drug delivery methods such as topical gels and injectables. Notably, the trend towards non-invasive treatments and the development of long-acting testosterone formulations are shaping the future of this market. As opportunities expand into emerging markets and telehealth solutions gain traction, the Male Hypogonadism Market is set to evolve significantly in the coming years.
MARKET INTRODUCTION
Male hypogonadism is a failure of the testes that produce the male test hormone testosterone, sperm, or both. It can be due to a testicular disorder or the result of a disease process involving the hypothalamus and pituitary gland.
MARKET DYNAMICS
The male hypogonadism market is anticipated to grow owing to increasing case of testosterone deficiency among men. However, high side effects is one of the major restraints for the market growth. Moreover, rising geriatric population all across the world coupled with rising cases of obesity and rheumatoid arthritis are expected to benefit the growth of the market in the forecast period.
MARKET SCOPE
The "Male Hypogonadism Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in male hypogonadism market with detailed market segmentation by therapy, drug delivery, type and geography. The male hypogonadism market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in male hypogonadism market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The male hypogonadism market is segmented on the basis of therapy, drug delivery and type. Based on therapy the market is segmented as testosterone replacement therapy and gonadotropin and gonadotropin-releasing hormones therapy. Further on the basis of gonadotropin and gonadotropin-releasing hormones therapy the market is segmented as luteinizing hormone (LH), follicle-stimulating hormone (FSH), human chorionic gonadotropin (hCG) and gonadotropin-releasing hormone (GnRH). On the basis of drug delivery the market is categorized as topical gels, injectable, transdermal patches and others. On the basis of type the market is categorized as klinefelter's syndrome, kallmann syndrome, pituitary disorders and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in male hypogonadism market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The male hypogonadism market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting male hypogonadism market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the male hypogonadism market in these regions.
MARKET PLAYERS
The report covers key developments in the in male hypogonadism market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in male hypogonadism market are anticipated to have lucrative growth opportunities in the future with the rising demand for in male hypogonadism market in the global market. Below mentioned is the list of few companies engaged in the male hypogonadism market.
The report also includes the profiles of key in male hypogonadism market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AbbVie Inc.
- Allergan plc
- Astrazeneca plc
- Bayer AG
- Eli Lilly and Company Ltd.
- Endo International plc.
- Finox Biotech,
- Laboratoires Genevrier
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Male Hypogonadism Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ XX million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2025 - 2031) | 5.1% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Therapy
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Frequently Asked Questions
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
Jean-Herve Jenn Chairman, Future Analytica
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
John Suzuki President and Chief Executive Officer, Board Director, BK TechnologiesReason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
1. AbbVie Inc.
2. Allergan plc
3. Astrazeneca plc
4. Bayer AG
5. Eli Lilly and Company Ltd.
6. Endo International plc.
7. Finox Biotech,
8. Laboratoires Genevrier
9. Merck & Co., Inc.
10. Teva Pharmaceutical Industries Ltd.
Get Free Sample For